Press release

Orthofix to Report Fourth Quarter and Full-Year 2025 Financial Results

Company to Host Conference Call on Tuesday, February 24, 2026, at 8:30 am Eastern Time LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc.

Orthofix Medical Inc.February 3, 20265
Orthofix to Report Fourth Quarter and Full-Year 2025 Financial Results

About this update from Orthofix Medical Inc.

Company to Host Conference Call on Tuesday, February 24, 2026 , at 8:30 am Eastern Time LEWISVILLE, Texas --(BUSINESS WIRE)-- Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2025 financial results on Tuesday, February 24, 2026 , before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S. , and (646) 968-2525 in all other locations, and referencing the conference ID 2236604. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com. Internet Posting of Information Orthofix regularly shares important updates in the “Investors” section of its website at www.orthofix.com . The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix . About Orthofix Orthofix is a global medical technology company headquartered in Lewisville, Texas . By providing medical technologies that heal musculoskeletal pathologies, Orthofix delivers exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH™ Navigation System. Learn more about our surgical and therapeutic solutions at Orthofix.com and follow us on LinkedIn . View source version on businesswire.com : https://www.businesswire.com/news/home/20260203972511/en/ Investor and Media Relations Julie Dewey , IRC Chief Investor Relations & Communications Officer [email protected] +1 209.613.6945 Source: Orthofix Medical Inc.

View stock analysis, news, and events for Orthofix Medical Inc.

More from Orthofix Medical Inc.

All Orthofix Medical Inc. news →